Funding at the intersection of healthcare and AI increased significantly over the past year, totaling over $7.5 billion globally, although it remains below 2021 peak levels. In 2025, early investments reached nearly $1.68 billion. Major funding rounds marked the past year, with Xaira Therapeutics receiving $1 billion for drug discovery, and Formation Bio securing $372 million for drug development. In early 2025, notable investments included Innovaccer's $275 million and Abridge's $250 million for AI-enabled healthcare platforms. The sector experienced successful exits, such as Tempus AI's public offering, while others like Metagenomi faced stock price declines. Investment activity remains strong, with expectations for continued growth in AI-focused health startups and a favorable outlook for biotech public offerings.

Learn more on this news visit us at: https://theweb3.news/news-bites/why-is-healthcare-and-ai-the-hottest-startup-trend-of-2025/

Hosted on Acast. See acast.com/privacy for more information.